NCT03992664View on ClinicalTrials.gov

Education Intervention in Patients with Rash Due to Epidermal Growth Factor Receptor (EGFR) Treatment.

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

January 1, 2019

Primary Completion Date

December 12, 2020

Study Completion Date

August 10, 2022

Conditions
Consent FormLung CancerColon CancerPancreas CancerHead and Neck CancerBreast Cancer
Interventions
OTHER

Educational training program

"The training program will focus on four parameters: cleanliness, hydration, protection from external stimuli, and finally early detection of skin side effects.~The re-evaluation of the skin as well as the repetition of the questionnaires will be done every week for 4 weeks."

Trial Locations (1)

7600

Eleni Papoui, Larnaca

All Listed Sponsors
lead

Cyprus University of Technology

OTHER

NCT03992664 - Education Intervention in Patients with Rash Due to Epidermal Growth Factor Receptor (EGFR) Treatment. | Biotech Hunter | Biotech Hunter